Review
Published on 15 Apr 2025
Current status of KRAS G12C inhibitors in NSCLC and the potential for combination with anti-PD-(L)1 therapy: a systematic review
in Cancer Immunity and Immunotherapy
- 369 views
Review
Published on 15 Apr 2025
in Cancer Immunity and Immunotherapy
Review
Published on 15 Apr 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Systematic Review
Published on 15 Apr 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Published on 15 Apr 2025
in Immunological Tolerance and Regulation
Review
Published on 15 Apr 2025
in Viral Immunology
Original Research
Published on 15 Apr 2025
in Inflammation
Original Research
Published on 15 Apr 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Review
Published on 15 Apr 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 15 Apr 2025
in Vaccines and Molecular Therapeutics
Mini Review
Published on 15 Apr 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Case Report
Published on 15 Apr 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 14 Apr 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 14 Apr 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 14 Apr 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 14 Apr 2025
in Inflammation
Editorial
Accepted on 14 Apr 2025
in Molecular Innate Immunity